Immunotech Biopharm Ltd
Company Profile
Business description
Immunotech Biopharm Ltd is a cellular immunotherapy biopharmaceutical company in China. The company is focused on the research, development, and commercialization of T-cell immunotherapy. Its product EAL is a multi-target cellular immunotherapy product for the treatment of various types of cancer. Its product pipeline features classes of cellular immunotherapy products, including both non-genetically modified and genetically modified products, as well as both multi-target and single-target products. Its other products include the CAR-T cell series and the TCR-T cell series.
Contact
No.1 Kangding Street
8th Floor, Block 1, Guosheng Technology Park
Beijing Economic-technological Development Area
Beijing100176
CHNT: +86 1088400152
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
154
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,365.70 | 24.70 | 0.30% |
CAC 40 | 7,593.87 | 38.00 | 0.50% |
DAX 40 | 22,496.98 | 71.15 | 0.32% |
Dow JONES (US) | 40,859.81 | 190.45 | 0.47% |
FTSE 100 | 8,496.80 | 1.95 | 0.02% |
HKSE | 22,119.41 | 111.30 | 0.51% |
NASDAQ | 17,781.28 | 334.94 | 1.92% |
Nikkei 225 | 36,452.30 | 406.92 | 1.13% |
NZX 50 Index | 12,148.60 | 245.29 | 2.06% |
S&P 500 | 5,623.95 | 54.89 | 0.99% |
S&P/ASX 200 | 8,145.60 | 19.40 | 0.24% |
SSE Composite Index | 3,279.03 | 7.62 | -0.23% |